Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Cash generated from core business operations
Latest
$-13.09M
↑ 88% vs avg
Percentile
P86
Within normal range
Streak
4 yr
Consecutive growthExpanding
Average
$-109.41M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-13.09M | +44.6% |
| 2024 | $-23.65M | +82.5% |
| 2023 | $-135.49M | +22.5% |
| 2022 | $-174.83M | +33.7% |
| 2021 | $-263.81M | -209.7% |
| 2020 | $-85.18M | -21.1% |
| 2019 | $-70.34M | +52.7% |
| 2018 | $-148.64M | -13.2% |
| 2017 | $-131.30M | -175.1% |
| 2016 | $-47.73M | - |